Riskpilot← Back to searchSign inGet full accessNOVIVIA AB
ABActiveOrg 5591600522Hasseluddsvägen 3Nursing and midwifery activities · NACE 8694Est. 20180 employees
Revenue 2025
SEK 448K
-16% vs 2024
EBITDA margin
74.0%
-15% vs 2024
Equity ratio
83.9%
Financial strength
Net profit 2025
SEK 263K
-16% vs 2024
| Revenue | SEK 448K | -16% |
| EBITDA | SEK 331K | -15% |
| Net profit | SEK 263K | -16% |
| Total assets | SEK 476K | +15% |
| Equity | SEK 399K | +3% |
| Employees | 0 | — |
Legal name
NOVIVIA AB
Org number
5591600522
Legal form
Aktiebolag
NACE code
8694 · Nursing and midwifery activities
Founded
24 maj 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Specialistsjuksköterska. Bedriva hälso- och sjukvård och därmed förenlig verksamhet, så som rekrytera och bedriva uthyrning av sjuksköterskor och läkare, telefonrådgivning, administration och ekonomiansvar för vårdbolag på uppdrag, annan öppen hälso- och sjukvård, utan läkare. Arbeta med fristående författarskap och därmed förenlig verksamhet.
Address
Hasseluddsvägen 3
Email
noviviaab@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 377 | 588 | 375 | 532 | 448 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 266 | 326 | 220 | 389 | 331 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 266 | 326 | 220 | 389 | 331 |
| Net financials | — | — | 0 | 5 | 1 |
| Profit before tax | 267 | 326 | 221 | 394 | 332 |
| Tax | −55 | −67 | −46 | −82 | −69 |
| Net profit | 212 | 259 | 174 | 312 | 263 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 362 | 462 | 334 | 413 | 476 |
| Equity | 291 | 350 | 274 | 386 | 399 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 71 | 112 | 60 | 27 | 77 |
| Total debt | 71 | 112 | 60 | 27 | 77 |
EBITDA margin
74.0%
This company
15.8%
Market median
+368% vs market
20212025
Equity ratio
83.9%
This company
38.2%
Market median
+120% vs market
20212025
Return on equity
65.9%
This company
18.4%
Market median
+258% vs market
20212025
Net profit margin
58.8%
This company
8.1%
Market median
+626% vs market
20212025
Asset turnover
0.94×
This company
1.12×
Market median
+16% vs market
20212025
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NOVIVIA AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sofia Ellinor Osseyran | Board of Directors | 0 companies |
| Mohannad Atef Osseyran | Deputy Board Member | 0 companies |
| Eva Johanna Johansson | Deputy Board Member | 0 companies |